Cromos Pharma successfully completes enrollment for a Phase II COVID-19 vaccine clinical trial
Cromos Pharma today (Thursday, 16 September, 2021) announced that it has successfully completed recruitment for a Phase II COVID-19 vaccine clinical trial. Cromos Pharma is pleased to achieve this important milestone for this vaccine study which will contribute to the ongoing fight against the COVID-19 pandemic.
This enrollment is the latest success for Cromos Pharma, a US-based international CRO, which specializes in patient recruitment. The company has an unparalleled track record in bringing success to clinical trials and overcoming patient recruitment challenges.
No Patients – No Payment
Utilizing its 16 years + experience in managing all aspects of clinical trials and its in-depth knowledge of its regions across Central and Eastern Europe, Cromos Pharma guarantees its patient recruitment promise with its unique No Patient – No Payment initiative.
Cromos Pharma is currently managing several clinical trials for COVID-19 treatments and vaccine candidates across our regions.
Contact us today at firstname.lastname@example.org to find out more about how Cromos Pharma can bring success to your next clinical project.
About Cromos Pharma
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.
Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Turkey to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials.
We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.
Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.